5 Most Promising Biotech Stocks According to Analysts

Page 1 of 5

In this article, we discuss 5 most promising biotech stocks according to analysts. If you want to see more stocks in this selection, check out 10 Most Promising Biotech Stocks According to Analysts

5. Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)

Number of Hedge Fund Holders: 25

Average Upside Potential as of February 24: 100.67%

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) was founded in 2008 and is headquartered in Boston, Massachusetts. The company develops a platform for cell programming, which is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) is one of the most promising biotech stocks. 

On November 28, Gaurav Goparaju, an analyst at Berenberg, began coverage of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) and assigned it a Buy rating with a $6 price target. Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) is utilizing its platform to commercialize synthetic biology on a large scale in various industries and is the only company with a widely-scaled horizontal platform in this field, according to the analyst. The analyst thinks that Ginkgo is in a favorable position to revolutionize cell programming in multiple industries.

According to Insider Monkey’s Q4 data, 25 hedge funds were long Ginkgo Bioworks Holdings, Inc. (NYSE:DNA), compared to 24 funds in the prior quarter. 

Follow Ginkgo Bioworks Holdings Inc.

Page 1 of 5